急性冠状动脉综合征生化标志物研究进展

Research Progress of Biochemical Marker in Acute Coronary Syndrome

急性冠状动脉综合征(ACS)是临床危重症,血液中生化标志物的测定是反映心肌损伤的重要手段之一,生化标志物凭其特异性及敏感性,在ACS诊断和危险分层中起着非常重要的作用。该文综述了骨髓相关蛋白、心肌肌钙蛋白、缺血修饰蛋白、妊娠相关蛋白A和心肌型脂肪酸结合蛋白5种生化标志物在ACS中的临床应用和最新进展。

Acute Coronary Syndrome is a clinical severe disease, The measurement of biochemical markers in blood is one of the most important methods to identify myocardial injury. Biochemical marker with their specificity and sensitivity play an important role in diagnosis and risk stratification of patients with Acute Coronary Syndrome（ACS）. this article is reviewed the clinical application and the latest research progress of Biochemical marker with MRP、cTn、IMA、PAPP-A、H-FABP in Acute Coronary Syndrome